Retrospective Study
Copyright ©The Author(s) 2025.
World J Gastrointest Oncol. May 15, 2025; 17(5): 103479
Published online May 15, 2025. doi: 10.4251/wjgo.v17.i5.103479
Figure 2
Figure 2 Class changes in body composition during treatment. Percentage changes in the prevalence of abnormal body composition from baseline to after the last systemic chemotherapy were shown. S: Sarcopenia; ScO: Subcutaneous obesity; M: Myosteatosis; mo: Months; VO: Visceral obesity.